Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Depreciation & Amortization (CF) (2020)

Silo Pharma (SILO) has disclosed Depreciation & Amortization (CF) for 1 consecutive years, with $185625.0 as the latest value for Q2 2020.

  • Quarterly Depreciation & Amortization (CF) changed N/A to $185625.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $185625.0 through Mar 2021, up 125.0% year-over-year, with the annual reading at $268125.0 for FY2020, 333.33% up from the prior year.
  • Depreciation & Amortization (CF) hit $185625.0 in Q2 2020 for Silo Pharma, up from $82500.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $185625.0 in Q2 2020 to a low of $82500.0 in Q1 2020.